Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-212-1 | CAS number: -
Carcinogenicity
Administrative data
Description of key information
A carcinogenicity study has not been proposed as it may be waived under the specific rules for adaptation to testing.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Carcinogenicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Cashew Nutshell Extract, Decarboxylated, Distillation Residue (Distilled Residue Grade) will not be classified for carcinogenicity as genotoxicity studies for this grade and also the read across substance Cashew (Anacardium occidentale) Nutshell Extract, Decarboxylated, Distilled are negative. Furthermore, neoplastic lesions or hyperplasia have not been identified in a 90-day repeated-dose study, and a carcinogenicity study is not required.
Detailed information on the Mode of Action is available in Chapter 3, Annex: Mode of action / Human relevance Framework [124]
Additional information
A carcinogenicity study has not been proposed for Cashew Nutshell Extract, Decarboxylated, Distillation Residue (Distillation Residue Grade) because it does not have a widespread dispersive use nor is there evidence of frequent long-term human exposure. Furthermore, the substance is not classified as mutagen category 3 nor is there evidence from a 90-day repeated dose toxicity study that the substance is able to induce hyperplasia and/or neoplastic lesions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
